Melatonin activates membrane-bound G-protein-coupled receptors mt1 and MT2, but may also bind a family of orphan nuclear receptors, including RORα and RZRβ, representing another potential molecular mechanism of melatonin action. Recently, we demonstrated that melatonin downregulates gonadotropin-releasing hormone (GnRH) gene expression in the GT1–7 cell line, specifically at the level of the neuron-specific GnRH gene enhancer. In this study, we have examined the region located at –1736/–1728 of the GnRH enhancer shown to be involved in the repression of GnRH by melatonin. This region includes hexameric consensus binding sites for orphan nuclear receptors, including ROR/RZR and COUP-TFI, as well as other defined consensus binding sites for AP-1 and C/EBP. Using electrophoretic mobility shift analysis (EMSA), we have demonstrated that GT1–7 nuclear proteins bind specifically to this region of the GnRH enhancer to form 4 complexes. EMSA antibody supershift analysis indicates that the transcription factors COUP-TFI and C/EBP beta bind two specific complexes, but RORα, Oct-1, Pbx-1, c-fos, or c-jun antibodies failed to produce any detectable supershifts. These results provide the first evidence that melatonin may mediate its direct neuroendocrine control of GnRH gene expression through transcription factor binding at specific regions of the GnRH enhancer.

1.
Aleandri V, Spina V, Morini A: The pineal gland and reproduction. Hum Reprod Update 1996;2:225–235.
2.
Vanecek J, Klein DC: A subpopulation of neonatal gonadotropin-releasing hormone sensitive pituitary cells is responsive to melatonin. Endocrinology 1993;133:360–367.
3.
Martin JE, Klein DC: Melatonin inhibition of the neonatal pituitary response to luteinizing hormone-releasing factor. Science 1976;191:301–302.
4.
Rasmussen DD: Diurnal modulation of rat hypothalamic gonadotropin-releasing hormone release by melatonin in vitro. J Endocrinol Invest 1993;16:1–7.
5.
Malpaux B, Thiery JC, Chemineau P: Melatonin and the seasonal control of reproduction. Nutr Dev 1999;39:355–366.
6.
Reppert SM, Weaver DR, Ebisawa T: Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994;13:1177–1185.
7.
Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA, Gusella JF: Molecular characterization of a second melatonin receptor expressed in human retina and brain: The Mel1b melatonin receptor. Proc Natl Acad Sci USA 1995;92:8734–8738.
8.
Carlberg C, Wiesenberg I: The orphan receptor family RZR/ROR, melatonin and 5-lipoxygenase: An unexpected relationship. J Pineal Res 1995;18:171–178.
9.
Wiesenberg I, Missbach M, Carlberg C: The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling. Restor Neurol Neurosci 1998;12:143–150.
10.
Mellon PL, Windle JJ, Goldsmith P, Pedula C, Roberts J, Weiner RI: Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron 1990;5:1–10.
11.
Whyte DB, Lawson MA, Belsham DD, Eraly SA, Bond CT, Adelman JP, Mellon PL: A neuron-specific enhancer targets expression of the gonadotropin-releasing hormone gene to hypothalamic neurosecretory neurons. Mol Endocrinol 1995;9:467–477.
12.
Nelson SB, Lawson MA, Kelley CG, Mellon PL: Neuron-specific expression of the rat gonadotropin-releasing hormone gene is conferred by interactions of a defined promoter element with the enhancer in GT1–7 cells. Mol Endocrinol 2000;14:1509–1522.
13.
Roy D, Angelini N, Frieda H, Brown GM, Belsham DD: Cyclical regulation of GnRH gene expression in GT1–7 GnRH-secreting neurons by melatonin. Endocrinology 2001;142:4711–4720.
14.
Clark ME, Mellon PL: The POU homeodomain transcription factor Oct-1 is essential for activity of the gonadotropin-releasing hormone neuron-specific enhancer. Mol Cell Biol 1995;15:6169–6177.
15.
Lawson MA, Whyte DB, Mellon PL: GATA factors are essential for activity of the neuron-specific enhancer of the gonadotropin-releasing hormone gene. Mol Cell Biol 1996;16:3596–3605.
16.
Lee KAW, Bindereif A, Green MR: A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal Techn 1988;5:22–31.
17.
Laemmli U: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–685.
18.
Schrader M, Danielsson C, Wiesenberg I, Carlberg C: Identification of natural monomeric response elements of the nuclear receptor RZR/ROR: They also bind COUP-TF homodimers. J Biol Chem 1996;271:19732–19736.
19.
Leng X, Cooney AJ, Tsai SY, Tsai MJ: Molecular mechanisms of COUP-TF-mediated transcriptional repression: Evidence for transrepression and active repression. Mol Cell Biol 1996;16:2332–2340.
20.
Zeitoun K, Takayama K, Michael MD, Bulun SE: Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. Mol Endocrinol 1999;13:239–253.
21.
Guerrero HY, Gauer F, Schuster C, Pevet P, Masson-Pevet M: Melatonin regulates the mRNA expression of the mt(1) melatonin receptor in the rat pars tuberalis. Neuroendocrinology 2000;71:163–169.
22.
Barrett P, MacLean A, Davidson G, Morgan PJ: Regulation of the Mel 1a melatonin receptor mRNA and protein levels in the ovine pars tuberalis: Evidence for a cyclic adenosine 3′,5′-monophosphate-independent Mel 1a receptor coupling and an autoregulatory mechanism of expression. Mol Endocrinol 1996;10:892–902.
23.
Molis TM, Spriggs LL, Hill SM: Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol Endocrinol 1994;8:1681–1690.
24.
Molis TM, Spriggs LL, Jupiter Y, Hill SM: Melatonin modulation of estrogen-regulated proteins, growth factors, and proto-oncogenes in human breast cancer. J Pineal Res 1995;18:93–103.
25.
Sainz RM, Mayo JC, Reiter RJ, Antolin I, Esteban MM, Rodriguez C: Melatonin regulates glucocorticoid receptor: An answer to its antiapoptotic action in thymus. FASEB J 1999;13:1547–1556.
26.
Sumova A, Vanecek J: Melatonin inhibits GnRH-induced increase of cFOS immunoreactivity in neonatal rat pituitary. J Neuroendocrinol 1997;9:135–139.
27.
Roy D, Belsham DD: Melatonin receptor activation regulates gonadotropin-releasing hormone (GnRH) gene expression and secretion in GT1–7 GnRH neurons: Signal transduction mechanisms. J Biol Chem 2002;277:251–258.
28.
Becker-Andre M, Wiesenberg I, Schaeren-Wiemers N, Andre E, Missbach M, Saurat JH, Carlberg C: Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem 1994;269:28531–28534.
29.
Wiesenberg I, Missbach M, Kahlen JP, Schrader M, Carlberg C: Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucl Acids Res 1995;23:327–333.
30.
Giguere V, Tini M, Flock G, Ong E, Evans RM, Otulakowski G: Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev 1994;8:538–553.
31.
Carlberg C, Hooft van Huijsduijnen R, Staple JK, DeLamarter JF, Becker-Andre M: RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Mol Endocrinol 1994;8:757–770.
32.
Roth J, Kim B, Lin W, Choi M: Melatonin promotes osteoblast differentiation and bone formation. J Biol Chem 1999;274:22041–22047.
33.
Giguere V: Orphan nuclear receptors: From gene to function. Endocr Rev 1999;20:689–725.
34.
Lethimonier C, Flouriot G, Kah O, Ducouret B: The glucocorticoid receptor represses the positive autoregulation of the trout estrogen receptor gene by preventing the enhancer effect of a C/EBPbeta-like protein. Endocrinology 2002;143:2961–2974.
35.
Achatz G, Holzl B, Speckmayer R, Hauser C, Sandhofer F, Paulweber B: Functional domains of the human orphan receptor ARP-1/COUP-TFII involved in active repression and transrepression. Mol Cell Biol 1997;17:4914–4932.
36.
Belsham DD, Mellon PL: Transcription factors Oct-1 and C/EBP b (CCAAT/enhancer-binding protein-b) are involved in the glutamate/nitric oxide/cyclic-guanosine 5′-monophosphate-mediated repression of mediated repression of gonadotropin-releasing hormone gene expression. Mol Endocrinol 2000;14:212–228.
37.
Schwartz C, Catez P, Rohr O, Lecestre D, Aunis D, Schaeffer E: Functional interactions between C/EBP, Sp1, and COUP-TF regulate human immunodeficiency virus type 1 gene transcription in human brain cells. J Virol 2000;74:65–73.
38.
Boulikas T: Phosphorylation of transcription factors and control of the cell cycle. Crit Rev Eukaryot Gene Expr 1995;5:1–77.
39.
Gay F, Barath P, Desbois-Le Peron C, Metivier R, Le Guevel R, Birse D, Salbert G: Multiple phosphorylation events control chicken ovalbumin upstream promoter transcription factor I orphan nuclear receptor activity. Mol Endocrinol 2002;16:1332–1351.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.